|Bid||13.30 x 800|
|Ask||13.98 x 800|
|Day's Range||12.84 - 14.01|
|52 Week Range||7.85 - 52.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 24, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||17.60|
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - September 23, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and reminds investors of the October 4, 2021 deadline to seek the role of lead plaintiff in a ...
Zymergen, which went public in April in a half-billion IPO, said it is conducting a "full assessment" of its target markets.
New York, New York--(Newsfile Corp. - September 23, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Zymergen Inc (NASDAQ: ZY).Shareholders who purchased shares of ZY during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zymergen-inc-los